These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 17261751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.
    Scuteri A, Tesauro M, Rizza S, Iantorno M, Federici M, Lauro D, Campia U, Turriziani M, Fusco A, Cocciolillo G, Lauro R.
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):349-56. PubMed ID: 17935958
    [Abstract] [Full Text] [Related]

  • 4. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.
    Sir-Petermann T, Angel B, Maliqueo M, Carvajal F, Santos JL, Pérez-Bravo F.
    Diabetologia; 2002 Jul; 45(7):959-64. PubMed ID: 12136394
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A, Gerhard-Herman MD, Williams JS, O'connor ME, Simonson DC.
    Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
    [Abstract] [Full Text] [Related]

  • 9. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ.
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T, Tsutsumi O, Taketani Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
    [Abstract] [Full Text] [Related]

  • 18. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
    Bik W, Baranowska-Bik A, Wolinska-Witort E, Chmielowska M, Martynska L, Baranowska B.
    Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856
    [Abstract] [Full Text] [Related]

  • 19. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF, Lieps D, Schatz H, Pfohl M.
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.